Decibel Therapeutics, Inc. Unbilled Receivables, Current
Decibel Therapeutics, Inc. had Unbilled Receivables, Current of $4.40 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2023-05-15
- 2023-03-31: Unbilled Receivables, Current $4.40M.
- 2022-12-31: Unbilled Receivables, Current $0.00.
- 2022-09-30: Unbilled Receivables, Current $10.00M.
- 2022-06-30: Unbilled Receivables, Current $10.00M.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2023-03-31 | $4.40M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-09-30 | $10.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $11.40M 10-K · filed 2023-03-14 |
| 2021-09-30 | $3.10M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.70M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $3.00M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.20M 10-K · filed 2022-03-18 |